1-(tert-Butoxycarbonyl)-5-(trifluoromethyl)piperidine-3-carboxylic acid

Catalog No.: 
ACTPRG659
CAS No.: 
1638761-15-5
Molecular Formula: 
C12H18F3NO4
Molecular Weight: 
297.27
1-(tert-Butoxycarbonyl)-5-(trifluoromethyl)piperidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$107.00In stockInquiry
1g95%$190.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)-5-(trifluoromethyl)piperidine-3-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)-5-(trifluoromethyl)piperidine-3-carboxylic acid
MDL No.MFCD28501399
Molecular FormulaC12H18F3NO4
Molecular Weight297.27
SMILESO=C(C1CN(C(OC(C)(C)C)=O)CC(C(F)(F)F)C1)O
InChI KeyNGBSMBNZYWUQCC-UHFFFAOYSA-N
SynonymPS-15479 | 1-[(2-methylpropan-2-yl)oxycarbonyl]-5-(trifluoromethyl)piperidine-3-carboxylic acid | NGBSMBNZYWUQCC-UHFFFAOYSA-N | P19963 | 1-[(tert-butoxy)carbonyl]-5-(trifluoromethyl)piperidine-3-carboxylic acid | CS-0184860 | SY321150 | MFCD28501399 | DTX
CAS No.1638761-15-5
PubChem CID126970290

Synthetic Route by SureRoute

1. ACTPRG659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLIY059 route compound structure diagram
    ACXLIY0592227206-57-5In Stock
  2. Then
  3. ACTPRG659 route product structure diagram
    ACTPRG6591638761-15-5In Stock
Inquiry

2. ACTPRG659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTPRG659 route product structure diagram
    ACTPRG6591638761-15-5In Stock
Inquiry

3. ACTPRG659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPRG659 route product structure diagram
    ACTPRG6591638761-15-5In Stock
Inquiry

Comments (0)